Get notified when NUTX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Securities Litigation (worsened) — Securities class action now has specific case details and a pending motion to dismiss, indicating progression.
  • Earn-out Share Disputes (worsened) — Former owners dispute share calculations, with ~256,005 shares under dispute, including ABQ Hospital's 216,039 shares.
NASDAQ: NUTX Nutex Health Inc. 10-Q

Nutex swings to $65.8M profit as arbitration costs flip to benefit; revenue falls 13.6%

Filed August 6, 2026 · Period ending June 30, 2026 · Compared to 10-Q Nov 18, 2025 · ~1 min read

Key Changes

  • high

    Total revenue fell 13.6% to $210.8M, with hospital division revenue down due to tough comparisons from 2025 IDR adjustments.

    MD&A: Revenue verify on EDGAR →
  • high

    Disclosure controls now deemed effective as of June 30, 2026, after prior material weaknesses were remediated; no material weaknesses disclosed.

    Controls verify on EDGAR →
  • medium

    spent on repurchases/retirements in H1 2026, reducing share count.

    MD&A: Capital verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (P 10-Q) is open in full — no account needed.

Partner

Trade NUTX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov View full financials on EDGAR ↗

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 8, 2026 · How we verify